Background: Multiple sclerosis is a chronic inflammatory disease of the central nervous system with a pronounced neurodegenerative component. It has been suggested that novel treatment options are ...

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

SAN DIEGO -- Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple sclerosis ... Tolebrutinib treatment also was associated ...

HOUSTON – Multiple ... on I.V. Steroids... Yeah. Life changes like that.” However, her doctors assure her (and all newly diagnosed patients) that this is an incredible time for treatment ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

Recently, rumors have surfaced about a possible diagnosis of multiple sclerosis ... treatments that can help manage symptoms and improve patients' quality of life. These include using steroids ...

help determine the extent of optic neuritis and the impact of treatment. Focus Point #3 Hemifield defects occur in multiple sclerosis but are frequently asymptomatic and usually result from large ...